Posterior Fossa Tumors

Abstract

In this article, we review the most common posterior fossa pediatric neoplasms. We describe the computed tomography and magnetic resonance imaging (MRI) findings used in the initial evaluation of a pediatric brain tumors. We also discuss the advanced MRI techniques which provide information about the physiology of the tumors and play an important role in the differential diagnosis as well as in the preoperative evaluation of different tumor types.

Keywords

pediatric posterior fossa tumor - pilocytic astrocytoma - medulloblastoma - ependymomas - brain stem glioma - magnetic resonance imaging

• References

• 1 Plaza MJ, Borja MJ, Altman N, Saigal G. Conventional and advanced MRI features of pediatric intracranial tumors: posterior fossa and suprasellar tumors. AJR Am J Roentgenol 2013; 200 (5) 1115-1124
• 2 Bornhorst M, Frappaz D, Packer RJ. Pilocytic astrocytomas. Handb Clin Neurol 2016; 134: 329-344
• 3 Chourmouzi D, Papadopoulou E, Konstantinidis M , et al. Manifestations of pilocytic astrocytoma: a pictorial review. Insights Imaging 2014; 5 (3) 387-402
• 4 Li J, Perry A, James CD, Gutmann DH. Cancer-related gene expression profiles in NF1-associated pilocytic astrocytomas. Neurology 2001; 56 (7) 885-890
• 5 Dunn IF, Agarwalla PK, Papanastassiou AM, Butler WE, Smith ER. Multiple pilocytic astrocytomas of the cerebellum in a 17-year-old patient with neurofibromatosis type I. Childs Nerv Syst 2007; 23 (10) 1191-1194
• 6 Hayostek CJ, Shaw EG, Scheithauer B , et al. Astrocytomas of the cerebellum. A comparative clinicopathologic study of pilocytic and diffuse astrocytomas. Cancer 1993; 72 (3) 856-869
• 7 Pencalet P, Maixner W, Sainte-Rose C , et al. Benign cerebellar astrocytomas in children. J Neurosurg 1999; 90 (2) 265-273
• 8 Christoforidis GA, Drevelegas A, Bourekas EC, Karkavelas G. Low-Grade Gliomas. In: Drevelegas A, ed. Imaging of Brain Tumors with Histological Correlations, 2nd ed. New York, NY: Springer; 2011
• 9 Louis DN, Perry A, Reifenberger G , et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 2016; 131 (6) 803-820
• 10 Chourmouzi D, Papadopoulou E, Marias K, Drevelegas A. Imaging of brain tumors. Surg Oncol Clin N Am 2014; 23 (4) 629-684
• 11 Nakano Y, Yamamoto J, Takahashi M , et al. Pilocytic astrocytoma presenting with atypical features on magnetic resonance imaging. J Neuroradiol 2015; 42 (5) 278-282
• 12 Alyeldien A, Teuber-Hanselmann S, Cheko A, Höll T, Scholz M, Petridis AK. Diffuse spinal leptomeningeal spread of a pilocytic astrocytoma in a 3-year-old child. Clin Pract 2016; 6 (1) 813
• 13 Rumboldt Z, Camacho DL, Lake D, Welsh CT, Castillo M. Apparent diffusion coefficients for differentiation of cerebellar tumors in children. AJNR Am J Neuroradiol 2006; 27 (6) 1362-1369
• 14 Tuntiyatorn L, Nantawas B, Sirachainan N, Larbcharoensub N, Visudtibhan A, Hongeng S. Apparent diffusion coefficients in evaluation of pediatric brain tumors. J Med Assoc Thai 2013; 96 (2) 178-184
• 15 Yamashita Y, Kumabe T, Higano S, Watanabe M, Tominaga T. Minimum apparent diffusion coefficient is significantly correlated with cellularity in medulloblastomas. Neurol Res 2009; 31 (9) 940-946
• 16 Rodriguez Gutierrez D, Awwad A, Meijer L , et al. Metrics and textural features of MRI diffusion to improve classification of pediatric posterior fossa tumors. AJNR Am J Neuroradiol 2014; 35 (5) 1009-1015
• 17 Kano H, Niranjan A, Kondziolka D , et al. Stereotactic radiosurgery for pilocytic astrocytomas part 2: outcomes in pediatric patients. J Neurooncol 2009; 95 (2) 219-229
• 18 Vassilyadi M, Shamji MF, Tataryn Z, Keene D, Ventureyra E. Postoperative surveillance magnetic resonance imaging for cerebellar astrocytoma. Can J Neurol Sci 2009; 36 (6) 707-712
• 19 Koeller KK, Rushing EJ. From the archives of the AFIP: medulloblastoma: a comprehensive review with radiologic-pathologic correlation. Radiographics 2003; 23 (6) 1613-1637
• 20 Packer RJ. Childhood medulloblastoma: progress and future challenges. Brain Dev 1999; 21 (2) 75-81
• 21 Smirniotopoulos JG. The new WHO classification of brain tumors. Neuroimaging Clin N Am 1999; 9 (4) 595-613
• 22 Bouffet E, Doz F, Demaille MC , et al. Improving survival in recurrent medulloblastoma: earlier detection, better treatment or still an impasse?. Br J Cancer 1998; 77 (8) 1321-1326
• 23 Burger PC, Grahmann FC, Bliestle A, Kleihues P. Differentiation in the medulloblastoma. A histological and immunohistochemical study. Acta Neuropathol 1987; 73 (2) 115-123
• 24 Levy RA, Blaivas M, Muraszko K, Robertson PL. Desmoplastic medulloblastoma: MR findings. AJNR Am J Neuroradiol 1997; 18 (7) 1364-1366
• 25 Katsetos CD, Herman MM, Frankfurter A , et al. Cerebellar desmoplastic medulloblastomas. A further immunohistochemical characterization of the reticulin-free pale islands. Arch Pathol Lab Med 1989; 113 (9) 1019-1029
• 26 Louis DN, Ohgaki H, Wiestler OD, Cavenee WK , eds. WHO Classification of Tumours of the Central Nervous System. 4th ed. Lyon, France: IARC Press; 2007
• 27 Sandhu A, Kendall B. Computed tomography in management of medulloblastomas. Neuroradiology 1987; 29 (5) 444-452
• 28 Zimmerman RA, Bilaniuk LT, Pahlajani H. Spectrum of medulloblastomas demonstrated by computed tomography. Radiology 1978; 126 (1) 137-141
• 29 Bourgouin PM, Tampieri D, Grahovac SZ, Léger C, Del Carpio R, Melançon D. CT and MR imaging findings in adults with cerebellar medulloblastoma: comparison with findings in children. AJR Am J Roentgenol 1992; 159 (3) 609-612
• 30 Meyers SP, Kemp SS, Tarr RW. MR imaging features of medulloblastomas. AJR Am J Roentgenol 1992; 158 (4) 859-865
• 31 Luh GY, Bird CR. Imaging of brain tumors in the pediatric population. Neuroimaging Clin N Am 1999; 9 (4) 691-716
• 32 Yamasaki F, Kurisu K, Satoh K , et al. Apparent diffusion coefficient of human brain tumors at MR imaging. Radiology 2005; 235 (3) 985-991
• 33 Chen Z, Ma L, Lou X, Zhou Z. Diagnostic value of minimum apparent diffusion coefficient values in prediction of neuroepithelial tumor grading. J Magn Reson Imaging 2010; 31 (6) 1331-1338
• 34 Le Bihan D, Turner R, Douek P, Patronas N. Diffusion MR imaging: clinical applications. AJR Am J Roentgenol 1992; 159 (3) 591-599
• 35 Pierce TT, Provenzale JM. Evaluation of apparent diffusion coefficient thresholds for diagnosis of medulloblastoma using diffusion-weighted imaging. Neuroradiol J 2014; 27 (1) 63-74
• 36 Majós C, Alonso J, Aguilera C , et al. Adult primitive neuroectodermal tumor: proton MR spectroscopic findings with possible application for differential diagnosis. Radiology 2002; 225 (2) 556-566
• 37 Davies NP, Wilson M, Harris LM , et al. Identification and characterisation of childhood cerebellar tumours by in vivo proton MRS. NMR Biomed 2008; 21 (8) 908-918
• 38 Moreno-Torres A, Martínez-Pérez I, Baquero M , et al. Taurine detection by proton magnetic resonance spectroscopy in medulloblastoma: contribution to noninvasive differential diagnosis with cerebellar astrocytoma. Neurosurgery 2004; 55 (4) 824-829 , discussion 829
• 39 Meyers SP, Wildenhain SL, Chang JK , et al. Postoperative evaluation for disseminated medulloblastoma involving the spine: contrast-enhanced MR findings, CSF cytologic analysis, timing of disease occurrence, and patient outcomes. AJNR Am J Neuroradiol 2000; 21 (9) 1757-1765
• 40 Rochkind S, Blatt I, Sadeh M, Goldhammer Y. Extracranial metastases of medulloblastoma in adults: literature review. J Neurol Neurosurg Psychiatry 1991; 54 (1) 80-86
• 41 Kondoff SI, Milev MD, Laleva LN , et al. A case of early extraneural medulloblastoma metastases in a young adult. Asian J Neurosurg 2015; 10 (4) 331-333
• 42 Koeller KK, Sandberg GD ; Armed Forces Institute of Pathology. From the archives of the AFIP. Cerebral intraventricular neoplasms: radiologic-pathologic correlation. Radiographics 2002; 22 (6) 1473-1505
• 43 Schneider JF, Confort-Gouny S, Viola A , et al. Multiparametric differentiation of posterior fossa tumors in children using diffusion-weighted imaging and short echo-time 1H-MR spectroscopy. J Magn Reson Imaging 2007; 26: 1390-1398
• 44 Barkovich AJ. Pediatric neuroimaging. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2000
• 45 Jaremko JL, Jans LB, Coleman LT, Ditchfield MR. Value and limitations of diffusion-weighted imaging in grading and diagnosis of pediatric posterior fossa tumors. AJNR Am J Neuroradiol 2010; 31 (9) 1613-1616
• 46 Louis DN, Ohgaki H, Wiestler OD, Cavenee WK , eds. WHO classification of tumours of the central nervous system. 4th ed. Lyon, France: The International Agency for Research on Cancer; 2007
• 47 Farwell JR, Dohrmann GJ, Flannery JT. Central nervous system tumors in children. Cancer 1977; 40 (6) 3123-3132
• 48 Panitch HS, Berg BO. Brain stem tumors of childhood and adolescence. Am J Dis Child 1970; 119 (6) 465-472
• 49 Epstein F. A staging system for brain stem gliomas. Cancer 1985; 56 (7, Suppl): 1804-1806
• 50 Freeman CR, Farmer JP. Pediatric brain stem gliomas: a review. Int J Radiat Oncol Biol Phys 1998; 40 (2) 265-271
• 51 Rubin G, Michowitz S, Horev G , et al. Pediatric brain stem gliomas: an update. Childs Nerv Syst 1998; 14 (4–5) 167-173
• 52 Epstein FJ, Farmer JP. Brain-stem glioma growth patterns. J Neurosurg 1993; 78 (3) 408-412
• 53 Epstein F, Constantini S. Practical decisions in the treatment of pediatric brain stem tumors. Pediatr Neurosurg 1996; 24 (1) 24-34
• 54 Robertson PL, Allen JC, Abbott IR, Miller DC, Fidel J, Epstein FJ. Cervicomedullary tumors in children: a distinct subset of brainstem gliomas. Neurology 1994; 44 (10) 1798-1803
• 55 Pollack IF, Hoffman HJ, Humphreys RP, Becker L. The long-term outcome after surgical treatment of dorsally exophytic brain-stem gliomas. J Neurosurg 1993; 78 (6) 859-863
• 56 Khuong-Quang DA, Buczkowicz P, Rakopoulos P , et al. K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol 2012; 124 (3) 439-447
• 57 Wu G, Diaz AK, Paugh BS , et al; St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project. The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat Genet 2014; 46 (5) 444-450
• 58 Taylor KR, Mackay A, Truffaux N , et al. Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma. Nat Genet 2014; 46 (5) 457-461
• 59 Zhang L, Chen LH, Wan H , et al. Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas. Nat Genet 2014; 46 (7) 726-730
• 60 Fontebasso AM, Papillon-Cavanagh S, Schwartzentruber J , et al. Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma. Nat Genet 2014; 46 (5) 462-466
• 61 Oka H, Utsuki S, Tanizaki Y , et al. Clinicopathological features of human brainstem gliomas. Brain Tumor Pathol 2013; 30 (1) 1-7
• 62 Frazier JL, Lee J, Thomale UW, Noggle JC, Cohen KJ, Jallo GI. Treatment of diffuse intrinsic brainstem gliomas: failed approaches and future strategies. J Neurosurg Pediatr 2009; 3 (4) 259-269
• 63 Mandell LR, Kadota R, Freeman C , et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys 1999; 43 (5) 959-964
• 64 Buczkowicz P, Bartels U, Bouffet E, Becher O, Hawkins C. Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications. Acta Neuropathol 2014; 128 (4) 573-581
• 65 Buczkowicz P, Hoeman C, Rakopoulos P , et al. Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations. Nat Genet 2014; 46 (5) 451-456
• 66 Farmer JP, Montes JL, Freeman CR, Meagher-Villemure K, Bond MC, O'Gorman AM. Brainstem Gliomas. A 10-year institutional review. Pediatr Neurosurg 2001; 34 (4) 206-214
• 67 Walker DA, Punt JA, Sokal M. Clinical management of brain stem glioma. Arch Dis Child 1999; 80 (6) 558-564
• 68 Poretti A, Meoded A, Huisman TA. Neuroimaging of pediatric posterior fossa tumors including review of the literature. J Magn Reson Imaging 2012; 35 (1) 32-47
• 69 Ullrich NJ, Raja AI, Irons MB, Kieran MW, Goumnerova L. Brainstem lesions in neurofibromatosis type 1. Neurosurgery 2007; 61 (4) 762-766 , discussion 766–767
• 70 Poussaint TY, Kocak M, Vajapeyam S , et al. MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC). Neuro-oncol 2011; 13 (4) 417-427
• 71 Löbel U, Sedlacik J, Reddick WE , et al. Quantitative diffusion-weighted and dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging analysis of T2 hypointense lesion components in pediatric diffuse intrinsic pontine glioma. AJNR Am J Neuroradiol 2011; 32 (2) 315-322
• 72 Panigrahy A, Blüml S. Neuroimaging of pediatric brain tumors: from basic to advanced magnetic resonance imaging (MRI). J Child Neurol 2009; 24 (11) 1343-1365
• 73 Seymour ZA, Panigrahy A, Finlay JL, Nelson Jr MD, Blüml S. Citrate in pediatric CNS tumors?. AJNR Am J Neuroradiol 2008; 29 (5) 1006-1011
• 74 Prabhu SP, Ng S, Vajapeyam S , et al. DTI assessment of the brainstem white matter tracts in pediatric BSG before and after therapy: a report from the Pediatric Brain Tumor Consortium. Childs Nerv Syst 2011; 27 (1) 11-18
• 75 Warren KE, Poussaint TY, Vezina G , et al. Challenges with defining response to antitumor agents in pediatric neuro-oncology: a report from the response assessment in pediatric neuro-oncology (RAPNO) working group. Pediatr Blood Cancer 2013; 60 (9) 1397-1401
• 76 Hipp SJ, Steffen-Smith E, Hammoud D, Shih JH, Bent R, Warren KE. Predicting outcome of children with diffuse intrinsic pontine gliomas using multiparametric imaging. Neuro-oncol 2011; 13 (8) 904-909
• 77 Steffen-Smith EA, Venzon DJ, Bent RS, Hipp SJ, Warren KE. Single- and multivoxel proton spectroscopy in pediatric patients with diffuse intrinsic pontine glioma. Int J Radiat Oncol Biol Phys 2012; 84 (3) 774-779
• 78 Giussani C, Poliakov A, Ferri RT , et al. DTI fiber tracking to differentiate demyelinating diseases from diffuse brain stem glioma. Neuroimage 2010; 52 (1) 217-223
• 79 Wang ZJ, Rao L, Bhambhani K , et al. Diffuse intrinsic pontine glioma biopsy: a single institution experience. Pediatr Blood Cancer 2015; 62 (1) 163-165
• 80 Pirotte BJ, Lubansu A, Massager N, Wikler D, Goldman S, Levivier M. Results of positron emission tomography guidance and reassessment of the utility of and indications for stereotactic biopsy in children with infiltrative brainstem tumors. J Neurosurg 2007; 107 (5, Suppl): 392-399
• 81 Corti M, Trione N, Risso D , et al. Disseminated paracoccidioidomycosis with a single brainstem lesion. A case report and literature review. Neuroradiol J 2010; 23 (4) 454-458
• 82 Adeolu AA. Safe surgical approach to deep pontomedullary cavernoma: an iMRI-assisted resection. Neurol India 2005; 53 (1) 121-122
• 83 Nimsky C. Intraoperative acquisition of fMRI and DTI. Neurosurg Clin N Am 2011; 22 (2) 269-277 , ix
• 84 Nimsky C, Ganslandt O, Buchfelder M, Fahlbusch R. Intraoperative visualization for resection of gliomas: the role of functional neuronavigation and intraoperative 1.5 T MRI. Neurol Res 2006; 28 (5) 482-487
• 85 Sun GC, Chen XL, Zhao Y , et al. Intraoperative MRI with integrated functional neuronavigation-guided resection of supratentorial cavernous malformations in eloquent brain areas. J Clin Neurosci 2011; 18 (10) 1350-1354
• 86 Zhang L, Chang-cun P, Li D. The historical change of brainstem glioma diagnosis and treatment: from imaging to molecular pathology and then molecular imaging. Chinese Neurosurgical Journal 2015; 1: 4
• 87 Louis DN, Ohgaki H, Wiestler OD , et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114 (2) 97-109
• 88 Tomita T, Grahovac G. Cerebellopontine angle tumors in infants and children. Childs Nerv Syst 2015; 31 (10) 1739-1750
• 89 Cristoforidis G, Drevelengas A, Bourekas E, Karkavelas G. Low Grade Gliomas. In: Drevelegas A, ed. Imaging of Brain Tumors with Histological Correlations. New York, NY: Springer; 2011: 43-47
• 90 Witt H, Mack SC, Ryzhova M , et al. Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. Cancer Cell 2011; 20 (2) 143-157
• 91 Thompson YY, Ramaswamy V, Diamandis P, Daniels C, Taylor MD. Posterior fossa ependymoma: current insights. Childs Nerv Syst 2015; 31 (10) 1699-1706
• 92 Jeffrey N Bruce Ependymoma Clinical Presentation. History, Physical, Causes. Available at http://emedicine.medscape.com/article/277621-clinical
• 93 Yuh EL, Barkovich AJ, Gupta N. Imaging of ependymomas: MRI and CT. Childs Nerv Syst 2009; 25 (10) 1203-1213
• 94 Rezai AR, Woo HH, Lee M, Cohen H, Zagzag D, Epstein FJ. Disseminated ependymomas of the central nervous system. J Neurosurg 1996; 85 (4) 618-624
• 95 Fangusaro J, Van Den Berghe C, Tomita T , et al. Evaluating the incidence and utility of microscopic metastatic dissemination as diagnosed by lumbar cerebro-spinal fluid (CSF) samples in children with newly diagnosed intracranial ependymoma. J Neurooncol 2011; 103 (3) 693-698
• 96 Blaser SI, Harwood-Nash DC. Neuroradiology of pediatric posterior fossa medulloblastoma. J Neurooncol 1996; 29 (1) 23-34
• 97 Hanzlik E, Woodrome SE, Abdel-Baki M, Geller TJ, Elbabaa SK. A systematic review of neuropsychological outcomes following posterior fossa tumor surgery in children. Childs Nerv Syst 2015; 31 (10) 1869-1875
• 98 Steinbok P, Hentschel S, Cochrane DD, Kestle JR. Value of postoperative surveillance imaging in the management of children with some common brain tumors. J Neurosurg 1996; 84 (5) 726-732
• 99 U-King-Im JM, Taylor MD, Raybaud C. Posterior fossa ependymomas: new radiological classification with surgical correlation. Childs Nerv Syst 2010; 26 (12) 1765-1772
• 100 Wilms G, Drevelegas A, Demaerel P, Sciot R. Embryonal Tumors in Imaging of Brain Tumors with Histological correlations. A. Drevelegas, ed. New York, NY: Springer- Verlag Berlin Heidelberg; 2011: 215-227